A Study of Carilizumab Combined With Concurrent Chemoradiotherapy

Clinical trial NCT05151549 · UNKNOWN

Trial details

NCT number: NCT05151549
Sponsor: Hunan Cancer Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Cervical Cancer

Start date: 2021-12-01
Primary completion: 2023-12-12
Enrollment: 46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.